Mahamaya Lifesciences IPO Details: Everything You Should Know about 

Check Expert’s Verdicts on Mahamaya Lifesciences IPO

The Mahamaya Lifesciences IPO will be open for bidding from 11th November to 13th November. It is a book-building issue of 2,900 crore shares. The issue is entirely a fresh issue of 9.88 crore shares. And an offer for sale of 3.48 crore shares. The IPO is expected to be listed on the BSE and NSE with a tentative listing date of 18th November 2025.

Mahamaya Lifesciences IPO Details

The Mahamaya Lifesciences IPO is expected to take place from 11th November 2025 to 13th November 2025. The face value of Mahamaya Lifesciences IPO shares is ₹1 per share, and the IPO price is set at ₹108 to ₹114 per share.

Kfin Technologies Limited is the registrar of the Mahamaya Lifesciences IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below.

Mahamaya Lifesciences IPO Details 

Mahamaya Lifesciences IPO Share Reservation

Mahamaya Lifesciences’ IPO is a book-building issue IPO of 70.44 Crore shares. Mahamaya Lifesciences Limited Shares will be listed on the BSE SME. Furthermore, SEBI has specified the share reservation criteria for different investor categories.

Mahamaya Lifesciences IPO GMP 

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Would you like to receive live updates on the Mahamaya Lifesciences IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of  11th November 2025, the Mahamaya Lifesciences IPO GMP stands at ₹0 per share, indicating that the share is likely to list at ₹114 on its tentative listing date, November 18, 2025.

GMP data is subject to change based on market trends and sentiments. Please verify the live GMP status before applying for the Mahamaya Lifesciences IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends. 

Mahamaya Lifesciences IPO Review

Review the detailed Mahamaya Lifesciences IPO review for a thorough understanding of its potential to deliver listing gains. The Mahamaya Lifesciences IPO review will help you invest effectively to avoid significant losses. Explore more to make an informed Investment decision on this IPO.

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Therefore, it is crucial to comprehend the business’s economic performance and trends before applying for the Mahamaya Lifesciences IPO.

Mahamaya Lifesciences Limited’s revenue increased by 64% from ₹162.83 crore in March 2024 to ₹267.17 crore in March 2025. Moreover, the company’s PAT increased by 148% from ₹5.22 crores to ₹12.94 crores. Investors can analyse other relevant factors and make a decision accordingly.

Mahamaya Lifesciences Limited’s IPO has shown consistent revenue growth, indicating the company’s financial stability. Moreover, brokers, investors, and RAs have a positive outlook for Mahamaya Lifesciences’s IPO on its tentative listing day.

Technical Analysis

Some technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Mahamaya Lifesciences IPO

The P/E ratio of Mahamaya Lifesciences Limited’s shares is 15.65, and its Earnings Per Share (EPS) is 7.29. Thus, the Mahamaya Lifesciences Limited IPO can deliver gains on its tentative listing day, 18th November 2025

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Mahamaya Lifesciences Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics. 

Mahamaya Lifesciences IPO Subscription Status

 The subscription status for the Mahamaya Lifesciences IPO is yet to be announced. Stay informed on this passage to check the live Mahamaya Lifesciences IPO subscription status. 

About the Mahamaya Lifesciences Limited Company Overview

Mahamaya Lifesciences Limited was established in 2007 and is engaged in the manufacturing, registration, and export of high-quality crop protection products and bioproducts for crop & soil health management, aiming to enhance productivity in the farming community. The company specialises in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs). The company imports carefully researched molecules, registers them with the Central Insecticides Board, and markets them as technical and value-added formulations for domestic manufacturers and multinational corporations (MNCs).

• Experienced management team consisting of experts.
• Capability to introduce vital products for Indian Agriculture.
• Development of export opportunities for products.
• Ability to develop brands.
• Cordial relationships with suppliers of raw materials.
• Core values focused on achieving sustainability through innovative approaches.

Mahamaya Lifesciences Limited Financials

The company’s financial analysis is essential before applying for Mahamaya Lifesciences Limited’s IPO. Refer to the table to learn about Mahamaya Lifesciences Limited’s financial information. 

Explanation

Mahamaya Lifesciences Limited’s revenue increased by 64% from ₹162.83 crore in March 2024 to ₹267.17 crore in March 2025. Moreover, the company’s PAT increased by 148% from ₹5.22 crores to ₹12.94 crores. Investors can analyse other relevant factors and make a decision accordingly.

Mahamaya Lifesciences IPO Promoter Holdings

Take a look at the table below to review the holdings of Mahamaya Lifesciences Limited’s promoters. Mr Krishnamurthy Ganesan, Mrs Lalitha Krishnamurthy, and Mr Prashant Krishnamurthy.

Note: The value will be calculated using Equity Dilution = Share Holding Pre-Issue –  Share Holding Post-Issue.

Mahamaya Lifesciences IPO Objectives

The primary objective of the Mahamaya Lifesciences IPO is to raise ₹2,900.00 crore. However, before applying for the IPO, it is essential to be aware of its secondary objectives. Explore them below

• Purchase of Equipment for the existing Formulation plant
• Funding capital expenditure towards setting up a new technical manufacturing plant
• Construction of Warehouse Building and Purchase of Machinery
• Funding the working capital requirement of our Company
• General Corporate purposes

Should I Invest in Mahamaya Lifesciences IPO?

Explore the pros and cons of Mahamaya Lifesciences IPO to decide whether to apply for it or avoid it. These pros and cons might help you understand the IPO’s potential to deliver profits in the coming decades.

Pros of Mahamaya Lifesciences IPO

• Company revenue is growing YoY with a substantial jump in FY23 and FY24.
• They work on newer pesticide molecules, which can give an early innovation advantage.
• They have export reach in multiple countries besides India.
• The distribution network in India is expanding, which helps drive sales.
• They are adding biological/eco-friendly agri products to their portfolio.

Cons of the Mahamaya Lifesciences IPO

• Revenue is highly dependent on a limited number of customers, which is risky.
• Raw materials are mainly imported, which means that fluctuations in foreign exchange can negatively impact margins.
• Agriculture demand is dependent on monsoon and crop cycles, so sales are seasonal and unpredictable.
• The quality of cash flow has not been robust recently.
• They are still small in size compared to big global agrochemical players.
• How to Invest in the Mahamaya Lifesciences IPO?

How to Invest in the Mahamaya Lifesciences IPO?

Please follow the steps outlined below to apply for a position at Mahamaya Lifesciences IPO Limited.

• Step 1: Conduct thorough research on the Mahamaya Lifesciences IPO, including GMP status, subscription status, issue size, lot size, and other relevant details. 
• Step 2: Open a demat account with Univest to gain real-time insights into GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Place a bid for two lots of 2,400 shares, valued at ₹2,73,600.
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Mahamaya Lifesciences IPO across multiple demat accounts to increase your chances of allotment. 

How to Check Mahamaya Lifesciences IPO Allotment Status?

You can check for the Mahamaya Lifesciences IPO allotment in different ways. These include BSE and the registrar portal. Follow the steps below to check your allotment status online.

Check On BSE

• Visit the BSE Official Website.
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Mahamaya Lifesciences IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal. 
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Mahamaya Lifesciences IPO allotment status.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!

Final Thoughts 

Mahamaya Lifesciences’ IPO is a Boobuilding IPO of ₹70.44 crore. The shares of Mahamaya Lifesciences IPO Limited will be listed on the BSE and SME on its tentative listing date of 18th November 2025. Researching the Mahamaya Lifesciences IPO, including its GMP status and reviews, is highly recommended to secure the desired profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Stay informed with Univest to get regular updates on the Mahamaya Lifesciences IPO, GMP, subscription, and more!

FAQs on Mahamaya Lifesciences IPO

How is the Mahamaya Lifesciences IPO?

Ans. As of 11th November 2025, the Mahamaya Lifesciences IPO GMP (Grey Market Premium) stands at 0. It indicates that the estimated listing price could be ₹114 per share. It is a book-building IPO of 70.44 crore shares. The face value of each share of Mahamaya Lifesciences IPO Limited is ₹10.

What is Mahamaya Lifesciences’ IPO price?

Ans. The Mahamaya Lifesciences IPO price range is ₹108.00 to ₹114.00 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 2,400 shares, worth ₹2,73,600. Moreover, HNIs are required to bid for a minimum of 3 lots (3,600 shares) worth ₹4,10,400.

Is the Mahamaya Lifesciences IPO a good investment?

Ans. Mahamaya Lifesciences Limited’s revenue increased by 64% from ₹162.83 crore in March 2024 to ₹267.17 crore in March 2025. Moreover, the company’s PAT increased by 148% from ₹5.22 crores to ₹12.94 crores. Investors can analyse other relevant factors and make a decision accordingly.

Who will be the registrar of the Mahamaya Lifesciences IPO?

Ans. According to recent updates, Kfin Technologies Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Mahamaya Lifesciences IPO GMP, allotment, and refund, you can contact Kfin Technologies Limited at  reachus@kfintech.com or 04067162222, 04079611000.

What is the issue size of the Mahamaya Lifesciences IPO?  

Ans. Mahamaya Lifesciences IPO is a book-building issue of 70.44 crore. Moreover, the IPO is set to open on 11th November 2025 and close on 13th November 2025. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Mahamaya Lifesciences IPO, wait for the Mahamaya Lifesciences IPO RHP and the Mahamaya Lifesciences IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.

Upcoming IPOs

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest in India

Also Explore

Univest Screeners